Windward Bio Group AG director Orbimed Advisors LLC buys $20M of stock, first buy in 12 months
The purchase raises the insider's holding by 221%, the filing shows. By the Insider Stock Trader: Alerts app. Information only, not investment advice.
Orbimed Advisors LLC, a director of Windward Bio Group AG (WWB), bought 1,176,471 shares on Nov 16 at an average price of $17.00, a total of $20 million, according to a Form 4 filed with the SEC on Nov 18.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The trade was reported within two business days, as Section 16 requires.
With this purchase the insider holds 1,708,103 shares, 221% more than before. Other Windward Bio Group AG insiders have also bought: Three insiders made open-market purchases within 14 days, a pattern known as a cluster buy.
Details from the SEC filing:
| Company | Windward Bio Group AG (WWB) |
|---|---|
| Insider | Orbimed Advisors LLC |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 1,176,471 |
| Average price | $17.00 |
| Value | $20,000,007 |
| Trade date | Nov 16, 2026 |
| Filed with the SEC | Nov 18, 2026, 5:08 PM ET |
| Shares held after | 1,708,103 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See the full details of this insider trade
See the latest cluster buys and sells · See all insider activity at Windward Bio Group AG
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.